Mouse blastocyst surface expression of galactose-containing epitopes coinciding with trophoblast differentiation.
A galactose-containing cell surface epitope of mouse blastocysts was identified and partially characterized by means of immuno- and lectincytochemistry, using a mouse IgM anti-blastocyst monoclonal antibody (mAb N63) and four different galactose-binding lectins (BSL-1, DBA, PNA and SBA) as molecular probes. The mAb was produced by syngeneic intrasplenic immunization with adhesive mouse blastocysts, obtained 18 h after estrogen reactivation from facultative delay of implantation. Labelling of different mouse embryonic stages collected by uterine flushings revealed that the labelling of the epitope by monoclonal antibodies was restricted to the blastocyst stage. A peak labelling intensity was observed on late blastocysts. When examining blastocyst outgrowths, both trophoblast and embryoblast were weakly stained by mAb N63. Direct antigen characterization performed on blastocysts indicated that the mAb N63 recognized a galactose-containing glycolipid antigen. Immunochemistry of cryosectioned, unfixed mouse tissues including ovary, testis, uterus in delay and at implantation, Day 12 and term placenta, liver, kidney, brain, intestine, heart, striated muscle, and skin was negative. In addition, labelling of rat and hamster blastocysts was negative. In vitro experiments demonstrated that the galactose-containing blastocyst surface epitope was not involved in blastocyst attachment to plastic culture dishes. The appearance of the epitope at the embryonic surface in vivo coincides with the time of trophoblast differentiation and implantation in the mouse.
Svalander
P C
PC
Department of Human Anatomy, Uppsala University, Sweden.
Hjortberg
M
M
Grönvik
K O
KO
Nilsson
B O
BO
D000818:Animals; D000911:Antibodies, Monoclonal / Q000378:metabolism; D001755:Blastocyst / Q000166:cytology / Q000378:metabolism* / Q000502:physiology; D002241:Carbohydrates / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects; D010064:Embryo Implantation / Q000187:drug effects; D000939:Epitopes / Q000235:genetics*; D005260:Female; D005690:Galactose / Q000276:immunology* / Q000378:metabolism / Q000494:pharmacology; D005786:Gene Expression Regulation; D037102:Lectins / Q000378:metabolism; D008565:Membrane Proteins / Q000235:genetics* / Q000378:metabolism / Q000494:pharmacology; D000432:Methanol / Q000494:pharmacology; D051379:Mice; D010504:Periodic Acid / Q000494:pharmacology; D011402:Pronase / Q000494:pharmacology; D014327:Trophoblasts / Q000166:cytology*; D014357:Trypsin / Q000494:pharmacology; D014992:Xylenes / Q000494:pharmacology
D000911:Antibodies, Monoclonal; D002241:Carbohydrates; D000939:Epitopes; D037102:Lectins; D008565:Membrane Proteins; D014992:Xylenes; D010504:Periodic Acid; D014357:Trypsin; D011402:Pronase; D005690:Galactose; D000432:Methanol